Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
About Index
Index
By TNW
Log in
Register
Autolus Ltd.
1643
Autolus Ltd.
Health Care
Medical
Pharmaceuticals
Autolus is a private biopharmaceutical company, focused on the development and commercialisation of engineered Tcell immunotherapy products with extreme efficacy in the treatment of lifethreatening cancers..
Suggest edits
Type
B2b
Founded
2014
Raised
$285.6M
Follow us
Also headquartered in London
Blockchain
Reuters
Springwise
BBC
Revolut
DeepMind
Volkswagen
HSBC
Cambridge Analytica
Ubuntu
Companies in the same industry
Vytrus Biotech
TransCure bioServices
Orientation Marketing
Heterotech
Medzy
PeptiMimesis
SCILEX Pharmaceuticals Inc.
Storm therapeutics
Doctrina
Esperion Therapeutics
Alexa global traffic share
Overview
Funding
3
Add info
Add round
22 Jun
2018
$150,000,000
IPO
Autolus goes public
PE HUB
26 Sep
2017
$80,000,000
Venture capital (Series C)
Cormorant Asset Management
,
Nextech Invest
,
Arix Bioscience
,
+2
03 Mar
2016
£40,000,000
Venture capital (Series B)
woodfordfunds
,
Perceptive Bioscience
UCL spin-out Autolus secures £40 million funding
Academic publication